Both rs3784929 (TERF2IP) and rs12696304 (TERC) variants are located within intron regions and thus may affect the transcription process, resulting in changes in the expression levels of the corresponding proteins, which may eventually contribute to inflammation and endothelial dysfunction during the development of AMR and CGD. Here, TERF2IP is linked to chronic granulomatous disease.